×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents tagged [partial response sd]
A Phase III study (EMBRACE*) of eribulin mesylate vs. treatment of physician’s choice in patients with locally recurrent or metastatic breast cancer previously
220 views
Pertuzumab e Trastuzumab-DM1. Filippo Montemuro, M.D. Divisione di Oncologia Medica 1 Fondazione del Piemonte per l’Oncologia/Istituto per la Ricerca e
215 views
Klinikum Grosshadern
65 views
Phase II Trial of Ipilimumab Monotherapy in Melanoma Patients with Brain Metastases
39 views
A paradigm shift in the treatment of advanced lung cancer: survival and symptom benefits with Tarceva Tudor-Eliade Ciuleanu Cancer Institute Ion Chiricuta
215 views
Results From Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment (PRECEPT): Second-Line Treatment With Panitumumab
213 views
Bevacizumab Update. ASCO 2007: an overview of highlighted Avastin trials in NSCLC Phase III NSCLC Subset analysis of ECOG 4599 Outcomes for elderly in
216 views
ALK and Other Evolving Targets in Advanced NSCLC Mark A. Socinski, MD Professor of Medicine and Thoracic Surgery Director, Lung Cancer Section, Division
213 views